SI0809498T1 - Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone - Google Patents

Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone

Info

Publication number: SI0809498T1
Authority: SI; Slovenia
Prior art keywords: pharmaceuitical; hydrocortisone; composition; topical application; application containing
Prior art date: 1995-02-06

Application number

SI9630680T

Other languages

English (en)

Slovenian (sl)

Inventor

Johan Georg Harmenberg

Ann Harriet Margareta Kristofferson

Original Assignee

Medivir Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-06

Filing date

1996-02-02

Publication date

2004-12-31

1996-02-02 Application filed by Medivir Ab filed Critical Medivir Ab

2004-12-31 Publication of SI0809498T1 publication Critical patent/SI0809498T1/xx

Links

MDCGTBRYRLWFJI-WDCKKOMHSA-N 2-amino-9-(2-hydroxyethoxymethyl)-3h-purin-6-one;(8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2.O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MDCGTBRYRLWFJI-WDCKKOMHSA-N 0.000 title 1
230000000699 topical effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

SI9630680T 1995-02-06 1996-02-02 Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone SI0809498T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9500114		1995-02-06
EP96902557A EP0809498B1 (fr)	1995-02-06	1996-02-02	Composition pharmaceutique a l'usage topique contenant de l'acyclovir et de l'hydrocortisone
PCT/SE1996/000124 WO1996024355A1 (fr)	1995-02-06	1996-02-02	Nouvelle combinaison pharmaceutique

Publications (1)

Publication Number	Publication Date
SI0809498T1 true SI0809498T1 (en)	2004-12-31

Family

ID=20396821

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9630680T SI0809498T1 (en)	1995-02-06	1996-02-02	Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone

Country Status (30)

Country	Link
US (2)	USRE39264E1 (fr)
EP (2)	EP1419803B1 (fr)
JP (2)	JP4260220B2 (fr)
KR (1)	KR100431042B1 (fr)
CN (1)	CN1131034C (fr)
AR (1)	AR002030A1 (fr)
AT (2)	ATE262907T1 (fr)
AU (1)	AU716809B2 (fr)
CA (1)	CA2211389C (fr)
DE (3)	DE69632034T2 (fr)
DK (1)	DK0809498T3 (fr)
DZ (1)	DZ1966A1 (fr)
ES (1)	ES2214528T3 (fr)
FI (1)	FI119415B (fr)
FR (1)	FR10C0038I2 (fr)
HK (1)	HK1004368A1 (fr)
HR (1)	HRP960034B1 (fr)
IL (1)	IL116913A0 (fr)
MA (1)	MA23800A1 (fr)
MY (1)	MY119365A (fr)
NO (1)	NO314220B1 (fr)
NZ (1)	NZ301407A (fr)
PT (1)	PT809498E (fr)
SA (1)	SA96160590B1 (fr)
SI (1)	SI0809498T1 (fr)
TN (1)	TNSN96024A1 (fr)
TW (1)	TW438585B (fr)
WO (1)	WO1996024355A1 (fr)
YU (1)	YU49477B (fr)
ZA (1)	ZA96527B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9601544D0 (en)	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
IT1287114B1 (it) *	1996-10-31	1998-08-04	Recordati Chem Pharm	Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
US7223387B2 (en)	1998-11-18	2007-05-29	Medivir Ab	Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
SE9803929D0 (sv) *	1998-11-18	1998-11-18	Medivir Ab	Antiviral formulation
US7655252B2 (en)	1999-04-28	2010-02-02	The Regents Of The University Of Michigan	Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) *	1999-04-28	2010-08-03	The Regents Of The University Of Michigan	Antimicrobial compositions and methods of use
FR2837102B1 (fr) *	2002-03-18	2004-10-08	Palbian Snc	Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) *	2003-06-04	2005-09-22	Nanobio Corporation	Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
NZ545748A (en) *	2003-08-29	2010-03-26	Ranbaxy Lab Ltd	Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
WO2005051931A2 (fr) *	2003-11-26	2005-06-09	Ranbaxy Laboratories Limited	Inhibiteurs de la phosphodiestérase
US7618950B2 (en) *	2004-07-07	2009-11-17	Arigen Pharmaceuticals, Inc.	Method for treatment and prevention of herpes zoster by topical application
WO2006105216A1 (fr) *	2005-03-30	2006-10-05	Novartis Ag	Famciclovir pour le traitement de l'herpes labial recurrent pendant une periode d'un jour
US20070054834A1 (en) *	2005-04-11	2007-03-08	Nanobio Corporation	Quaternary ammonium halides for treatment of infectious conditions
US20070036831A1 (en) *	2005-08-09	2007-02-15	Nanobio Corporation	Nanoemulsion compositions having anti-inflammatory activity
WO2007031838A1 (fr)	2005-09-16	2007-03-22	Ranbaxy Laboratories Limited	Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
US7797337B2 (en) *	2005-09-29	2010-09-14	Scenera Technologies, Llc	Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
EP1948164A1 (fr)	2005-10-19	2008-07-30	Ranbaxy Laboratories, Ltd.	Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
RU2008119322A (ru) *	2005-10-19	2009-11-27	Рэнбакси Лабораториз Лимитед (In)	Композиции ингибиторов фосфодиэстеразы iv типа
FR2900577B1 (fr) *	2006-05-04	2008-09-12	Goemar Lab Sa	Nouveaux medicaments pour les traitements contre le virus de l'herpes
JP2010504323A (ja) *	2006-09-22	2010-02-12	ランバクシーラボラトリーズリミテッド	Ｉｖ型ホスホジエステラーゼの阻害物質
WO2008035316A2 (fr) *	2006-09-22	2008-03-27	Ranbaxy Laboratories Limited	Inhibiteurs de phosphodiestérase
US20080207659A1 (en) *	2007-02-15	2008-08-28	Asit Kumar Chakraborti	Inhibitors of phosphodiesterase type 4
DK2124944T3 (da)	2007-03-14	2012-04-23	Ranbaxy Lab Ltd	Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
US20110130403A1 (en) *	2007-03-14	2011-06-02	Ranbaxy Laboratories Limited	Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
US8524690B2 (en) *	2007-04-26	2013-09-03	The Trustees Of The University Of Pennsylvania	DNA polymerase inhibitors composition and methods
WO2008137747A1 (fr)	2007-05-02	2008-11-13	The Regents Of The University Of Michigan	Compositions thérapeutiques à base de nanoémulsion et leurs procédés d'utilisation
JP4972062B2 (ja) *	2008-03-17	2012-07-11	メディヴィル・アクチエボラーグ	抗ウイルス製剤
EP2111861A1 (fr)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Compositions d'inhibiteurs de type IV de la phosphodiestérase
US20090291895A1 (en) *	2008-05-23	2009-11-26	Wong Scott W	Methods and Compositions for the Treatment of Inflammatory Diseases
WO2011035120A2 (fr) *	2009-09-17	2011-03-24	Gk Ventures, L.L.C.	Composition thérapeutique pour traiter des lésions provoquées par le virus herpès simplex
CN102049050B (zh) *	2009-11-02	2014-06-18	重庆华邦制药有限公司	抗疱疹病毒感染的药物组合物
EP2489354A1 (fr) *	2011-02-18	2012-08-22	Vironova AB	Formulation pharmaceutique de B220 pour le traitement topique de l'herpès
ITMI20111747A1 (it) *	2011-09-28	2013-03-29	Fidia Farmaceutici	Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) *	2011-12-07	2014-04-25	Univ Paris Descartes	Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
US10682370B2 (en) *	2013-03-13	2020-06-16	Nal Pharmaceutical Group Limited	Topical antiviral composition containing a local anesthetic and method of making the same
CN104324039A (zh) *	2014-10-20	2015-02-04	付茜	一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) *	2018-07-18	2018-11-23	豆立忠	一种多药物模块软膏及其制备方法
WO2020036545A1 (fr) *	2018-08-17	2020-02-20	İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş.	Composition topique à phases stables comprenant de l'acyclovir et de l'hydrocortisone
JP2022538782A (ja)	2019-06-14	2022-09-06	プロペラセラピューティクスインコーポレイテッド	局所用アシクロビル製剤およびその使用
KR102478608B1 (ko) *	2019-06-25	2022-12-19	아주대학교산학협력단	허피스 감염증 마우스 모델의 제조방법
CN112569243A (zh) *	2019-09-30	2021-03-30	神农医药科技有限公司	制备治疗阿尔茨海默病的药物
US20230346829A1 (en) *	2020-05-11	2023-11-02	Revir, Inc.	Compositions and methods for treating viral infections
CN112704154A (zh) *	2020-12-24	2021-04-27	中国人民解放军66399部队	一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en)	2022-08-22	2024-04-09	Ford Therapeutics, Llc	Composition of chlorhexidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3317384A (en)	1964-06-08	1967-05-02	Upjohn Co	Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) *	1980-01-24	1985-04-23	Inwood Louis R	Dermatological composition useful in the treatment of psoriasis
US4902678A (en) *	1982-02-12	1990-02-20	Syntex (U.S.A.) Inc.	Anti-viral compositions
US4610868A (en)	1984-03-20	1986-09-09	The Liposome Company, Inc.	Lipid matrix carriers for use in drug delivery systems
US5223263A (en)	1988-07-07	1993-06-29	Vical, Inc.	Liponucleotide-containing liposomes
EP0594224A3 (en) *	1985-09-17	1994-07-13	Wellcome Found	Therapeutic nucleosides
US4942031A (en)	1988-02-23	1990-07-17	Levin Robert H	Compositions containing LYCD and other topically active medicinal ingredients
US5023090A (en) *	1989-08-16	1991-06-11	Levin Robert H	Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
WO1990006775A1 (fr) *	1988-12-14	1990-06-28	Liposome Technology, Inc.	Nouvelle composition de liposomes non phospholipidique a liberation soutenue de medicaments
AU636255B2 (en) *	1990-11-05	1993-04-22	Arthropharm Pty Ltd	Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) *	1991-03-01	1999-01-05	Warner Lambert Company	Therapeutic antiviral-wound healing compositions and methods for preparing and using same
DE69232706T2 (de) *	1991-05-01	2002-11-28	Henry M. Jackson Foundation For The Advancement Of Military Medicine, Rockville	Verfahren zur behandlung infektiöser respiratorischer erkrankungen
IL104283A (en) *	1992-12-30	1996-12-05	Agis Ind 1983 Ltd	Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) *	1993-07-30	1993-09-15	Wellcome Found	Stabilized formulation
DZ1965A1 (fr) *	1995-02-06	2002-07-17	Astra Ab	Composition pharmaceutique nouvelle.
GB9601544D0 (en)	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals

1996
- 1996-01-10 TW TW085100236A patent/TW438585B/zh not_active IP Right Cessation
- 1996-01-10 DZ DZ960007A patent/DZ1966A1/fr active
- 1996-01-23 HR HR960034A patent/HRP960034B1/xx not_active IP Right Cessation
- 1996-01-23 ZA ZA96527A patent/ZA96527B/xx unknown
- 1996-01-26 IL IL11691396A patent/IL116913A0/xx not_active IP Right Cessation
- 1996-02-02 KR KR1019970705356A patent/KR100431042B1/ko not_active IP Right Cessation
- 1996-02-02 EP EP03028943A patent/EP1419803B1/fr not_active Expired - Lifetime
- 1996-02-02 US US10/771,259 patent/USRE39264E1/en not_active Expired - Lifetime
- 1996-02-02 DE DE69632034T patent/DE69632034T2/de not_active Expired - Lifetime
- 1996-02-02 JP JP52418996A patent/JP4260220B2/ja not_active Expired - Lifetime
- 1996-02-02 DE DE122010000032C patent/DE122010000032I1/de active Pending
- 1996-02-02 CN CN96192868A patent/CN1131034C/zh not_active Expired - Lifetime
- 1996-02-02 WO PCT/SE1996/000124 patent/WO1996024355A1/fr active IP Right Grant
- 1996-02-02 AU AU46821/96A patent/AU716809B2/en not_active Expired
- 1996-02-02 NZ NZ301407A patent/NZ301407A/xx not_active IP Right Cessation
- 1996-02-02 DE DE69637828T patent/DE69637828D1/de not_active Expired - Fee Related
- 1996-02-02 AT AT96902557T patent/ATE262907T1/de active
- 1996-02-02 ES ES96902557T patent/ES2214528T3/es not_active Expired - Lifetime
- 1996-02-02 DK DK96902557T patent/DK0809498T3/da active
- 1996-02-02 AT AT03028943T patent/ATE421358T1/de not_active IP Right Cessation
- 1996-02-02 US US08/612,847 patent/US6337324B1/en not_active Ceased
- 1996-02-02 SI SI9630680T patent/SI0809498T1/xx unknown
- 1996-02-02 EP EP96902557A patent/EP0809498B1/fr not_active Expired - Lifetime
- 1996-02-02 CA CA002211389A patent/CA2211389C/fr not_active Expired - Lifetime
- 1996-02-02 PT PT96902557T patent/PT809498E/pt unknown
- 1996-02-05 TN TNTNSN96024A patent/TNSN96024A1/fr unknown
- 1996-02-05 MA MA24155A patent/MA23800A1/fr unknown
- 1996-02-05 AR ARP960101279A patent/AR002030A1/es active IP Right Grant
- 1996-02-06 MY MYPI96000423A patent/MY119365A/en unknown
- 1996-02-06 YU YU7296A patent/YU49477B/sh unknown
- 1996-02-10 SA SA96160590A patent/SA96160590B1/ar unknown
1997
- 1997-08-05 NO NO19973612A patent/NO314220B1/no not_active IP Right Cessation
- 1997-08-06 FI FI973243A patent/FI119415B/fi not_active IP Right Cessation
1998
- 1998-04-29 HK HK98103634A patent/HK1004368A1/xx not_active IP Right Cessation
2007
- 2007-08-02 JP JP2007201681A patent/JP2007284452A/ja active Pending
2010
- 2010-08-17 FR FR10C0038C patent/FR10C0038I2/fr active Active

Also Published As

Publication number	Publication date
USRE39264E1 (en)	2006-09-05
WO1996024355A1 (fr)	1996-08-15
CN1179718A (zh)	1998-04-22
NZ301407A (en)	1999-01-28
DE69632034D1 (de)	2004-05-06
DE69632034T2 (de)	2004-10-14
MA23800A1 (fr)	1996-10-01
PT809498E (pt)	2004-06-30
ATE262907T1 (de)	2004-04-15
JPH11506417A (ja)	1999-06-08
MY119365A (en)	2005-05-31
JP4260220B2 (ja)	2009-04-30
ZA96527B (en)	1996-08-06
US6337324B1 (en)	2002-01-08
IL116913A0 (en)	1996-05-14
CN1131034C (zh)	2003-12-17
DZ1966A1 (fr)	2002-10-15
FR10C0038I1 (fr)	2010-10-15
EP0809498B1 (fr)	2004-03-31
AU716809B2 (en)	2000-03-09
AU4682196A (en)	1996-08-27
HRP960034A2 (en)	1997-10-31
DE122010000032I1 (de)	2010-10-21
NO314220B1 (no)	2003-02-17
SA96160590B1 (ar)	2005-10-05
TW438585B (en)	2001-06-07
CA2211389A1 (fr)	1996-08-15
EP1419803A2 (fr)	2004-05-19
EP1419803B1 (fr)	2009-01-21
TNSN96024A1 (fr)	2005-03-15
DE69637828D1 (de)	2009-03-12
EP1419803A3 (fr)	2004-06-09
KR100431042B1 (ko)	2004-06-16
FI973243L (fi)	1997-08-06
JP2007284452A (ja)	2007-11-01
FI119415B (fi)	2008-11-14
CA2211389C (fr)	2007-11-20
FI973243A0 (fi)	1997-08-06
KR19980701959A (ko)	1998-06-25
ES2214528T3 (es)	2004-09-16
YU7296A (sh)	1998-08-14
FR10C0038I2 (fr)	2011-04-29
NO973612D0 (no)	1997-08-05
EP0809498A1 (fr)	1997-12-03
HK1004368A1 (en)	1998-11-27
AR002030A1 (es)	1998-01-07
YU49477B (sh)	2006-05-25
ATE421358T1 (de)	2009-02-15
HRP960034B1 (en)	2002-02-28
NO973612L (no)	1997-09-26
DK0809498T3 (da)	2004-05-10

Publication	Publication Date	Title
SI0809498T1 (en)	2004-12-31	Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone
AU6775098A (en)	1998-10-20	Topical moisturizing composition and method
AU7524496A (en)	1997-05-29	Stable avidin composition and methods using same
AU5449296A (en)	1996-11-07	Antiperspirant composition and manufacturing method
AU3002495A (en)	1996-01-25	Cure-indicating molding and coating composition
HU9503623D0 (en)	1996-02-28	Topical composition containing antagonic substance p
EP0777496A4 (fr)	1997-11-12	Composition anti-inflammatoire topique et procede associe
AU4139196A (en)	1996-05-31	Method and composition for antiviral therapy
AU1589995A (en)	1995-08-21	Anti-withering composition for pines and anti-withering method
AU5979496A (en)	1996-12-30	Composition and methods for losing weight
AU2076495A (en)	1995-10-03	Road surfacing composition and process
EP0759457A3 (fr)	1997-10-01	Composition de revêtement contenant du silicone résistant aux intempéries et aux salissures
GB2298713B (en)	1999-12-15	Method and composition
AU4266596A (en)	1996-08-07	Composition and use
AU6765896A (en)	1997-03-19	Antistatic composition and process for making same
EP0736578A3 (fr)	1997-04-23	Composition de revêtement et son utilisation
PL323103A1 (en)	1998-03-16	Composition containing amoxycyclin and clavulanic acid
AU5773696A (en)	1996-12-11	Improvements in and relating to fixing
AU2310395A (en)	1995-10-23	Topical retinal-based composition
AU6368394A (en)	1994-10-11	Polymer-polypeptide composition and method
EP0829526A4 (fr)	1999-02-24	Composition a cristaux liquides
AUPN137895A0 (en)	1995-03-16	Composition and method
AU7717894A (en)	1995-03-22	Method and composition for weight reduction
AU2550397A (en)	1998-10-20	Topical moisturizing composition and method
AU3991997A (en)	1998-04-09	Process for forming silica film and composition therefor